| Update on 18F-fluciclovine PET for prostate cancer imaging EE Parent, DM Schuster Journal of Nuclear Medicine 59 (5), 733-739, 2018 | 128 | 2018 |
| Synthesis and biological evaluation of [18F] bicalutamide, 4-[76Br] bromobicalutamide, and 4-[76Br] bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging EE Parent, CS Dence, C Jenks, TL Sharp, MJ Welch, ... Journal of medicinal chemistry 50 (5), 1028-1040, 2007 | 56 | 2007 |
| Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m PET imaging of estrogen receptors HM Bigott, E Parent, LG Luyt, JA Katzenellenbogen, MJ Welch Bioconjugate chemistry 16 (2), 255-264, 2005 | 51 | 2005 |
| ACR–ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer B Savir-Baruch, KP Banks, JE McConathy, OP Molchanova-Cook, ... Clinical nuclear medicine 43 (12), 909-917, 2018 | 48 | 2018 |
| [18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0 C Nanni, L Zanoni, T Bach-Gansmo, H Minn, F Willoch, TV Bogsrud, ... European journal of nuclear medicine and molecular imaging 47, 579-591, 2020 | 47 | 2020 |
| [18F]Fluciclovine PET discrimination between high- and low-grade gliomas EE Parent, M Benayoun, I Ibeanu, JJ Olson, CG Hadjipanayis, DJ Brat, ... EJNMMI research 8, 1-11, 2018 | 44 | 2018 |
| Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-γ ligands: potential positron emission tomography imaging agents BC Lee, CS Dence, H Zhou, EE Parent, MJ Welch, JA Katzenellenbogen Nuclear medicine and biology 36 (2), 147-153, 2009 | 42 | 2009 |
| Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br] bromo-hydroxyflutamide EE Parent, C Jenks, T Sharp, MJ Welch, JA Katzenellenbogen Nuclear medicine and biology 33 (6), 705-713, 2006 | 37 | 2006 |
| PET/MRI for the body imager: abdominal and pelvic oncologic applications TJ Fraum, KJ Fowler, J McConathy, EE Parent, F Dehdashti, PW Grigsby, ... Abdominal imaging 40, 1387-1404, 2015 | 26 | 2015 |
| Synthesis of 7α-(fluoromethyl) dihydrotestosterone and 7α-(fluoromethyl) nortestosterone, structurally paired androgens designed to probe the role of sex hormone binding … EE Parent, KE Carlson, JA Katzenellenbogen The Journal of Organic Chemistry 72 (15), 5546-5554, 2007 | 26 | 2007 |
| Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F] fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2, 3 … EE Parent, CS Dence, TL Sharp, MJ Welch, JA Katzenellenbogen Nuclear medicine and biology 33 (5), 615-624, 2006 | 22 | 2006 |
| Fifty years of radiopharmaceuticals P Brugarolas, J Comstock, DW Dick, T Ellmer, JW Engle, SE Lapi, ... Journal of nuclear medicine technology 48 (Supplement 1), 34S-39S, 2020 | 20 | 2020 |
| 18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors K Gauvain, MR Ponisio, A Barone, M Grimaldi, E Parent, H Leeds, ... Neuro-Oncology Practice 5 (1), 28-36, 2018 | 19 | 2018 |
| Advances and future directions in molecular breast imaging MF Covington, EE Parent, EH Dibble, GM Rauch, AM Fowler Journal of Nuclear Medicine 63 (1), 17-21, 2022 | 17 | 2022 |
| [18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis EE Parent, D Patel, JA Nye, Z Li, JJ Olson, DM Schuster, MM Goodman EJNMMI research 10, 1-9, 2020 | 16 | 2020 |
| Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients P Advani, S Chumsri, T Pai, Z Li, A Sharma, E Parent Annals of Nuclear Medicine 35 (11), 1264-1269, 2021 | 13 | 2021 |
| Mechanistic analysis of the photocycloaddition of silyl-tethered alkenes SA Fleming, AA Parent, EE Parent, JA Pincock, L Renault The Journal of Organic Chemistry 72 (25), 9464-9470, 2007 | 13 | 2007 |
| 177Lu-PSMA therapy EE Parent, B Savir-Baruch, IW Gayed, F Almaguel, BB Chin, AR Pantel, ... Journal of nuclear medicine technology 50 (3), 205-212, 2022 | 11 | 2022 |
| A treatment paradigm shift: targeted radionuclide therapies for metastatic castrate resistant prostate cancer EE Parent, AM Kase Cancers 14 (17), 4276, 2022 | 9 | 2022 |
| Training the next generation of radiopharmaceutical scientists AD Gee, J Andersson, R Bhalla, YS Choe, DW Dick, MM Herth, ... Nuclear medicine and biology 88, 10-13, 2020 | 9 | 2020 |
